Journal articleEur Rev Med Pharmacol Sci2018
MiR-210 knockdown promotes the development of pancreatic cancer via upregulating E2F3 expression.
- Journal
- Eur Rev Med Pharmacol Sci
- Published
- 1 December 2018
- Citations
- 36
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Objective The aim of this study was to explore the role of microRNA-210 (miR-210) and E2F3 in the development of pancreatic cancer and to investigate the possible underlying mechanism. Patients and methods The expression level of miR-210 in pancreatic cancer tissues, para-cancerous tissues, and normal pancreatic tissues was detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). … Excerpt only: this text is the publisher’s. Read it in full at the source.